EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions.
Costa JR Jr, Abizaid A, Feres F, Costa R, Seixas AC, Maia F, Abizaid A, Tanajura LF, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa AG, Fitzgerald P, Sousa JE.
Costa JR Jr, et al. Among authors: yan j.
EuroIntervention. 2008 May;4(1):53-8. doi: 10.4244/eijv4i1a10.
EuroIntervention. 2008.
PMID: 19112779
Clinical Trial.